Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Imprint’s DepotOne needle achieves CE Mark

12.10.2004


Imprint Pharmaceuticals (www.imprintpharma.com) is pleased to announce that its DepotOne needle technology has received its CE Mark and is now cleared for use in Europe. This CE Approval means that the DepotOne needle can be incorporated into clinical studies and existing products with minimal additional regulatory work.



DepotOne is a ‘small’ needle which can replace large needles. It has the penetration characteristics of a small needle with the flow of a large needle. The needle delivers highly viscous materials and will eliminate the need to resort to an unacceptably large needle for subcutaneous or intramuscular injections.

DepotOne is revolutionary as it enables higher doses to be injected. A higher deliverable dose means that new therapeutic products can be developed which have substantially improved product characteristics. The technology is particularly applicable for slow release or depot injectables including pegylated compounds, polymers and highly concentrated protein formulations.


Marketers are fully aware of the significant problems posed by the use of larger needles to the reputation and marketability of an injectable therapeutic product. Thus companies are planning to use DepotOne to reduce the impact of the large needle issue so the positive aspects of their product can be highlighted.

The technology is now being used in a number of clinical trials for high value long acting injectable therapeutics. Kevin Maynard, Business Development Director of Imprint Pharmaceuticals said “DepotOne creates a sea change in the presentation of injectable therapeutics. No longer do patients need to be faced with unacceptably large needles. I believe DepotOne will play a vital role in lowering the resistance to uptake of many of the new biological therapies coming through pharmaceutical companies’ product development lines.”

Imprint Pharmaceuticals Ltd is a centre of expertise in complex injectables. The company supplies tools to enhance the delivery and manufacture of these problematic formulations. Imprint has a range of patented injection devices which enhance the delivery of formulations containing particulates, viscous materials, gels and polymers. In addition, Imprint provides consultancy and patented technologies to enable rapid formulation and scale up of manufacture. Our expertise and patented technologies extend the range of complex injectable products enabling our clients to gain a commercial edge.

Dr Kevin Maynard | alfa
Further information:
http://www.Imprintpharma.com
http://www.oxin.co.uk/

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>